Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
Status:
Completed
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and efficacy of Sofosbuvir
containing regimens in treatment-naive or treatment-experienced patients with HCV genotype 3
infection.
Phase:
Phase 3
Details
Lead Sponsor:
Humanity & Healthy GI and Liver Centre Humanity and Health Research Centre
Collaborator:
Beijing 302 Hospital
Treatments:
Ledipasvir Ledipasvir, sofosbuvir drug combination Sofosbuvir